Cicatrizing and antimicrobial properties of an ozonised oil from sunflower seeds

Inflammopharmacology

Volumn 12, Issue 3, 2004, Pages 261-270

  Leite Rodrigues, Kamila ^a   Catellani Cardoso, Claudia ^b   Caputo, Lucelia Regina ^c   Tavares Carvalho, Jose Carlos ^d   Evangelista Fiorini, Joao ^a   Schneedorf, Jose Mauricio ^d  

^a Lab Biol Fisiol de Microrganismos   (Brazil)

^b UNIVERSITY OF MILAN   (Italy)

^c Laboratorio Patologia Experimental   (Brazil)

^d Unifenas   (Brazil)

Author keywords

Cicatrizing activity; Nosocomial infection; Ozonised oil

Indexed keywords

BIOPEROXOIL; CLOSTEBOL; NEOMYCIN; SUNFLOWER OIL;

AGAR GEL DIFFUSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; ESCHERICHIA COLI; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; RAT STRAIN; SALMONELLA TYPHIMURIUM; SKIN PROTECTION; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; MALE; MICROBIAL SENSITIVITY TESTS; PLANT OILS; RATS; RATS, WISTAR; SKIN; WOUND HEALING;

EID: 8844250057     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/1568560042342275     Document Type: Article

References (27)

1. Bocci, V. (2000). Ozonoterapia. Comprensione dei meccanismi di azione e possibilità terapeutiche, 1st edn. Casa Editrice Ambrosiana, Milan.
2. Candido, L. C. (2001). Nova abordagem no tratamento de feridas. Senac-SP, Sao Paulo.
3. Cardoso, C. C., Macêdo, S. B., Carvalho, J. C. T., et al. (2002). Azione dell'Olio ozonizzato (Bioperoxoil®) nelle lesione chirurgiche dei modelli pre-clinici, Farm. Ter. (Int. J. Drug Ther.) 19, 56-60.
4. Cooper, R. A., Molan, P. C. and Harding, K. G. (2002). The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds, J. Appl. Microbiol. 93, 857-863.
5. Cordeiro, J. C. R., Reis, A. O., Miranda, E. A., et al. (2001). In vitro antimicrobial activity of the aminoglycoside Arbekacin tested against oxacillin-resistent S. aureus isoleted in brazilian hospitals, Braz. J. Infect. Dis. 5, 130-135.
6. Ge, Y., MacDonald, D. L., Holroyd, K. J., et al. (1999). In vitro antibacterial properties of Pexiganan, an analog of magainin, Antimicrob Agents Chemother. 43, 782-788.
7. Gomez, M., Contreras, R. and Menendez, S. (1989). Efecto de la sustitucion del aceite de oliva por aceite de girasol sobre la actividad antimicrobiana de aceites ozonizados, Rev. CENIC Cienc. Quim. 20, 121-123.
8. Gurley, B. (1985). Ozone: pharmaceutical sterililant of the future?, J. Parent. Sci. Technol. 39, 256-261.
9. Ledea, O., Moleiro, J., Díaz, M., et al. (1997). Analisis de ozonidos y compuestos peroxidicos en la ozonizacion del oleato de metilo, Rev. CENIC. Ciênc. Quím. 29, 75-78.
10. Lerner, R. A. and Eschenmoser, A. (2003). Ozone in biology, Proc. Natl. Acad. Sci. USA 100, 3013-3015.
11. Lezcano, N., Nunez, M., Espino, M., et al. (2000). Antibacterial activity of ozonised sunflower oil, oleozón, against S. aureus and S. epidermidis, Ozone Sci. Eng. 22, 207-214.
12. Martínez, J. L. and Fernando, B, (2002). Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistence, Clin. Microbiol. Rev. 15, 647-679.
13. Mendez, R. A. (1988). Cimetidina vs. agua ozonificada em el tratamiento de la ulcera gastroduodenal, Rev. Cub. Med. 27, 7-13.
14. Menendez, S., Falcon, L., Simon, D. R., et al. (2002). Efficacy of ozonised sunflower oil in the treatment of tinea pedis, Mycoses 45, 329-332.
15. NCCLS, National Committee for Clinical Laboratory Standards (2002). Performance standards for antimicrobial disk susceptibility test: approved standard M2-A6, 6th edn. NCCLS, Wayne, PA.
16. Nichols, R. L. (2001). Preventing surgical site infections: a surgeon's pespective, Emerg. Infect. 7, 220-224.
17. Rodriguez, L. M., Cepero, S. M. and Perdomo, E. (1994). Efectos del ozono em el tratamiento de la gingivoestomatitis herpética aguda, Rev. Cub. Estomat. 31, 14-17.
18. Sanseverino, R. (1989). Aspetti iminologici dell'ozonoterapia, Riv. Ital. Omotossicol. 3, 19-24.
19. Sechi, L. A., Lezcano, I., Nunez, N., et al. (2001). Antibacterial activity of ozonised sunflower oil (Oleozon), J. Appl. Microbiol. 90, 279-284.
20. Siqueira, J. R., Roças, I. N., Cardoso, C. C., et al. (2000). Efeitos antibacterianos de um novo medicamento - o óleo ozonizado - comparados às pastas de hidróxido de cálcio, Rev. Bras. Odontol. 4, 252-256.
21. Speroni, E., Govoni, P., Guizzard, S., et al. (2002). Anti-inflamatory and cicatrizing activity of Echinacea pallida Nutt. root extract, J. Ethnopharmacol. 79, 265-272.
22. Ubaldi, A. (1998). Relazione sulle prove di tossicita' acuta, tossicita' sub-acuta e di calcolo della DL50 del prodotto bioperoxoil (Della Ditta Ozoñoil s.l.). Thesis, Università degli studi Parma, Facota'Di Medicina Veterinaria, Parma.
23. Valdéz, A. R., Cepero, S. M., Moraleda, M. G., et al. (1989). La ozonoterapia em la claudicacion intermitente de evolucion desfavorable, Rev. Cub. Cir. 28, 543-548.
24. Weinstein, R. A. (1998). Nosocomial infection update, Emerg. Infect. Dis. 4, 416-422.
25. Wentworth, P., Nieva, J., Takeuchi, C., et al. (2003). Evidence of ozone formation in human atheroclerotic arteries, Science 302, 1053-1056.
26. Wolf, A. (1915). Eine medizinische Verwendbarkeit des Ozons, Dtsch. Med. Wschr. 311, 1-5.
27. Yau, Y. H., Ho, B., Tan, N. S., et al. (2001). High therapeutic index of factor sushi peptides: potent antimicrobials against P. aeruginosa, Antimicrob. Agents Chemother. 45, 2820-2825.